Had tirelessly worked to build 930 flats for urban poor; current MLA stalled it: Lobo

News Network
February 28, 2019

Mangaluru, Feb 27: Mangaluru City South MLA D Vedavyasa Kamath is supporting a group of environmentalists whose petition to the Forest Department has led to the stalling of work on the urban poor housing project at Padavu in Shaktinagar, according to his predecessor J R Lobo.

Talking to reporters here on Wednesday, the Congress leader and former MLA said he worked tirelessly to get the approval of the State and the Union governments for building 930 flats for the urban poor at a cost of Rs. 69.5 crore in the nine-acre government land in 2017.

“Having completed 75% of the work and after calling for tenders, environment groups raised objection that made the department keep on hold its permission to clear trees in the nine-acre deemed forest area.

The environmentalists raised objections at the instance of Mr. Kamath,” he said. Mr. Lobo said the project has been stalled since July 2018 and Mr. Kamath, who heads the taluk-level Ashraya Samiti, has not made any effort so far to get the project moving. 

Mr. Lobo alleged that Mr. Kamath falsely blamed him during a review meeting, chaired by Nalin Kumar Kateel, MP, recently.

Denying the charges, Mr. Kamath told media persons that he was making efforts to set right the faults in implementing the project.

He said the law clearly stated that the government land, where there are more than 50 trees, becomes a deemed forest.

“Despite knowing this fact, Mr. Lobo, who has served in various positions as a government servant, went ahead with the project in the deemed forest area without getting necessary clearance.”

When the issue about the project came up for discussion during the meeting of Mr. Kateel, Mr. Kamath said he pointed the legal issue. “I did not blame Mr. Lobo but pulled up officials for the folly.”

The MLA said based on his letter, Mangaluru City Corporation Commissioner Mohammed Nazeer has written to the Deputy Commissioner Sasikanth Senthil S. for grant of land in the name of MCC that will facilitate construction of flats.

Comments

True Muslim
 - 
Thursday, 28 Feb 2019

Dear Lobo, dont tell we will not give flat to muslims.

 

because majority christian is worried if there is any muslim family present in flat.

 

in one hand you show good and other hand you backstab.

 

hindus are far more better then marons like your community.

 

we fought freedom together without your people. and we are still bothers

 

Jai hind

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
July 23,2020

Mangaluru, Jul 23: A nurse who was serving as a frontline COVID warrior at the Wenlock Hospital in Mangaluru and has recently tested positive along with her 7-year-old son has complained to the Deputy Commissioner against the harassment meted out by some miscreants who have been spreading false rumours against her.

Health official said that some people in her area have given false complaints against her to government officials thus inflicting mental torture on her and her family.

In her letter, the nurse has stated that the attitude of the people forcing her to consider quitting the job. "I have served the people by treating my work as worship. Anti-social elements have been torturing me now. I am very much hurt," the she said. 

The nurse’s house at Moodbidri has been sealed after she was tested positive. However, her husband and younger child were tested negative.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 16,2020

Udupi, Jan 16: Admar Mutt Junior seer Eshapriya Theertha Swami is all set to take over the reins of Krishna Mutt during the 250th Paryayotsava, scheduled to be held on January 17 and 18.

The uniqueness lies in the fact that the Admar Mutt, one of the Ashta Mutts of Krishna Mutt in this Temple town Udupi, ushers in the new Paryaya cycle (32nd). The Paryaya of outgoing seer Vidyadheesha Theertha Swami of Palimaru Mutt, Admar’s dwandwa (associate) mutt, marks the end of the cycle of eight mutts.

Under the system initiated by the Madhwa philosopher and saint Madwacharya, the seers of Ashta mutts would take turns to worship Lord Krishna every two months. Seer Vadiraja (1481-1601) ended the system and introduced the system of f running the temple administration once in two years.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.